Tert-butyl (2R)-2-[(2S)-1-cyclohexylidene-3-oxopropan-2-yl]piperidine-1-carboxylate
C19H31NO3 — CID 102193332
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (2R)-2-[(2S)-1-cyclohexylidene-3-oxopropan-2-yl]piperidine-1-carboxylate
Tert-butyl (2R)-2-[(2S)-1-cyclohexylidene-3-oxopropan-2-yl]piperidine-1-carboxylate (PubChem CID 102193332) has the molecular formula C19H31NO3 and a molecular weight of 321.46 g/mol. Its IUPAC name is tert-butyl (2R)-2-[(2S)-1-cyclohexylidene-3-oxopropan-2-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl (2R)-2-[(2S)-1-cyclohexylidene-3-oxopropan-2-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 102193332 |
| Molecular Formula | C19H31NO3 |
| Molecular Weight | 321.46 g/mol |
| Exact Mass | 321.23 |
| IUPAC Name | tert-butyl (2R)-2-[(2S)-1-cyclohexylidene-3-oxopropan-2-yl]piperidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCCC[C@@H]1[C@@H](C=O)C=C1CCCCC1 |
| InChI | InChI=1S/C19H31NO3/c1-19(2,3)23-18(22)20-12-8-7-11-17(20)16(14-21)13-15-9-5-4-6-10-15/h13-14,16-17H,4-12H2,1-3H3/t16-,17-/m1/s1 |
| InChIKey | RSKCTKHEIOJNIQ-IAGOWNOFSA-N |
| XLogP | 4.48 |
| TPSA | 46.61 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 321.46 |
| LogP ≤ 5 | 4.48 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 102193332 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.